George A. Fisher

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

George A. Fisher

Mar 28, 2025, 12:26 | Science

Cathy Eng: The Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer

Cathy Eng, Professor of Medicine, Hematology and Oncology, and is the Co-Director of GI Oncology,…

Jan 8, 2025, 14:32 | Blog

Aakash Desai: Autogene cevumeran redefining personalized cancer treatment

Aakash Desai, Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared on LinkedIn: "mRNA-based Immunotherapy…

Jul 18, 2024, 09:35 | Insight

ctDNA variant-specific differences as potential mPDAC prognostic biomarker - PICI

Parker Institute for Cancer Immunotherapy (PICI) shared a post on X about a recent paper titled…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023